Alharthi	“Pre-Ramadan” Telemedicine: Effect on Fasting Experience & Glycemic Control during Ramadan in People with Type 1 Diabetes	A1
Arnold	Smart Insulin Pen Integrates New Sensors and Connects to AI for Insulin Dose Calculation	A2
Arrieta	Real-World Outcomes of the MiniMed™ 780G System When Used with Optimal Setting	A3
Arunachalam	Impact of Real-World MiniMed™ 670G System Use on Glycemic Outcomes in the United States	A4
Baumann	Regression Modelling between Statistical Rigor and Clinical Implementation - The Benefits of Open Communication among Disciplines	A5
Beck	Improvements in Hypoglycemia and HbA1c with RT-CGM Adoption: Results from the COACH Study	A6
Bosoni	Relationship between Time in Range, Glycemic Variability Metrics and Daily Scan Rate in Children with Type 1 Diabetes	A7
Brew-Sam	Diabetes Technology Experiences of Young People Living with Type 1 Diabetes and Their Parents – Analysis Guided by a Hybrid Theoretical Foundation	A8
Bunsick	Inexpensive Regular Human Insulin Used with CGM Provides Similar Outcomes to More Expensive Insulin Lispro	A9
Button	1,5-Anhydroglucitol Is an Independent Predictor of Mortality in Patients with COVID-19	A10
Champakanath	Long-Term (7-Year) Glycemic Outcomes with Continuous Glucose Monitoring (CGM) Initiation within First Year of Type 1 Diabetes (T1D) Diagnosis	A11
Chattaraj	Rate of Unexplained Hyperglycemia and Infusion Set Occlusion: Medtronic Extended Infusion Set (EIS) Pivotal Trial and 3-Day Infusion Set Study Comparison	A12
Chien, A.	Potential Cost Savings from a Reduction in Sensor-Detected Severe Hypoglycemia among Users of the InPen Smart Insulin Pen System	A13
Chien, D.	Diabetic Eye Disease and Virtual Assistant AI: Do They Help Our Patients?	A14
Cox	Virtual Care in the COVID-19 Era: Assessing Telemedicine Experiences among Diabetes Care and Education Specialists	A15
Dugas	Development of Self-Management Behavior Scores and Profiles with Digital Health Data	A16
Fogle	Current Technology Use in Pediatric Patients with Type 1 Diabetes: An Equity-Focused Analysis	A17
Gadiraju	I Am Diabetic: Can I Speak to Virtual Assistants in Different Languages?	A18
Garelli	Outpatient Full Closed-Loop Trial Using an Open-Source Remote Monitoring and Artificial Pancreas Platform	A19
Haldimann	Increased Time-in-Range after Meals When Using the SNAQ App	A20
Idi	Unsupervised Anomaly Detection Algorithms to Identify Compression Artifacts in Continuous Glucose Monitoring	A21
Ilkowitz	Identifying Patients at High Risk for Cystic Fibrosis Related Diabetes through the Use of the Freestyle LibrePro CGM	A22
Jimenez	How Telemedicine Assists Adults with Type 2 Diabetes Obtain Adequate Glucose Control	A23
Kaiserman	Higher Dose of Inhaled Technosphere Insulin Provides Significant Reduction in Post Prandial Glucose Excursions, without Hypoglycemia	A24
Kamecke	Clinical Evaluation of the Lumee™ Glucose System – a Fluorescence-Based Long-Term Continuous Glucose Sensor	A25
Kesserwan	Phenolic Preservatives, Present in Commercial Insulins, Trigger Inflammation at Infusion Sites via Mast Cell Activation	A26
Kinzel	The Influence of Health Insurance on the CGM System Choice of a Type 1 Diabetic	A27
Lalani	Evaluation of the Safety and Efficacy of the Lalani Insulin Infusion Protocol	A28
McHugh	Determining Losses in Jet-Injection Subcutaneous Insulin Delivery	A29
Mujahid	Generation of Realistic Virtual Diabetes Patients Using a Pix2Pix GAN: In Pursuit of an AI-Based Diabetes Simulator	A30
Narayan	Predicting Postprandial Glucose Excursions with Nutrient Content Using an Interpretable Random Forest Augmented by a Digital Twin ODE Model	A31
Newson	Preferences for Connected Insulin Pens: A Discrete Choice Experiment among Type 1 and Type 2 Diabetes Patients	A32
Nosrati	Development of the Microfluidic Bio-Artificial “mPancreas”: A Scalable and Modular Microfluidic-Based Biomimetically-Designed Bio-Artificial Pancreas	A33
Oehme	Method to Test and to Validate ML/AI SaMD	A34
Ormsbee	Can EGP Be Estimated from Heart Rate?	A35
Owen	Representing Type 1 Diabetes Device Data Using CDISC Standards	A36
Pinsker	Significant Reductions in Adverse Events and Hospitalizations with Control-IQ Technology in Adults with Type 1 Diabetes: Data from the CLIO Study	A37
Potts	Wearable Electrochemical Platform for Glucose Monitoring and Diabetes Management	A38
Redding	Transdermal Insulin Patch-No Needles	A39
Rivera	Si Cuentas, Come Lo Que Quieras. Carbcounting Quiz App	A40
Romero-Ugalde	Hyperoptimized Deep Learning Model for Glucose Prediction on DBLG1	A41
Roversi	In Silico Trial to Quantitatively Measure How Much Different Behavioural Factors Influence Time in Hypoglycemia in Type 1 Diabetes Management	A42
Sears	The Effects of One Drop Digital Program on Glucose Control in Employees with Type 1 and 2 Diabetes	A43
Sears	The Effects of One Drop Digital Program on Weight Reduction in Overweight and Obese Employees with Prediabetes	A44
Setford	Post-market Clinical Surveillance of OneTouch Ultra® Plus Blood Glucose Test Strips	A45
Shah	A Data-Driven Approach to Predict Carbohydrate Counting Errors in Diabetes Management	A46
Siviero	Importance of Accounting for Correlation among Noise Samples When Filtering CGM Data: A Simulation Study	A47
Stroh	Point-of-Care Insulin Monitoring Using Electrochemical Sensing	A48
Taylor	User Experiences with an Insulin Pen Platform	A49
Wartenberg	CxM - Novel Sensors	A50
Wu	Can I Talk to Amazon Alexa and Google about Diabetic Kidney Disease?	A51
Wuttke	Upcycling of Used CGM to a Cool Chain Monitor for Insulin	A52
Zimmermann	Effect of Personalized Feedback Using Motivational Interviewing Strategies on the Frequency of Self-Monitoring of Blood Glucose and Subsequent Glycemic Control in Adults with Type 2 Diabetes	A53